Thursday 4 September 2014

India regulator says Sun's takeover of Ranbaxy may hurt competition

A man carrying gas cylinder walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai India's antitrust regulator said on Thursday it had made an initial observation that Sun Pharmaceutical Industries Ltd's agreed $3.2 billion acquisition of Ranbaxy Laboratories Ltd could hurt competition, asking the companies to provide more details. Sun and Ranbaxy have been asked by the regulator to publish details of the deal within 10 working days on their websites as well as in four national newspapers. Sun Pharma agreed in April to buy Ranbaxy from Japan's Daiichi Sankyo Ltd to create the world's fifth-largest maker of generic drugs.




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment